Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Molecular and cytological features of the mouse B-cell lymphoma line iMycEμ-1

Seong Su Han1 email, Arthur L Shaffer2 email, Liangping Peng1 email, Seung Tae Chung1 email, Jae Hwan Lim3,6 email, Sungho Maeng4 email, Joong Su Kim1,6 email, Nicole McNeil5 email, Thomas Ried5 email, Louis M Staudt2 email and Siegfried Janz1 email

Laboratory of Genetics, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA

Metabolism Branch, CCR, NCI, NIH, Bethesda, MD, USA

Laboratory of Metabolism, CCR, NCI, NIH, Bethesda, MD, USA

Laboratory of Cellular Carcinogenesis and Tumor Promotion, CCR, NCI, NIH, Bethesda, MD, USA

Genetics Branch, CCR, NCI, NIH, Bethesda, MD, USA

Korea Research Institutes of Bioscience and Biotechnology, Daejeon (J. S. K.) and Department of Biological Sciences, Andong National University, Andong, South Korea (J. H. L.)

author email corresponding author email

Molecular Cancer 2005, 4:40doi:10.1186/1476-4598-4-40

Published: 9 November 2005

Abstract

Background

Myc-induced lymphoblastic B-cell lymphoma (LBL) in iMycEμ mice may provide a model system for the study of the mechanism by which human MYC facilitates the initiation and progression of B cell and plasma cell neoplasms in human beings. We have recently shown that gene-targeted iMycEμ mice that carry a His6-tagged mouse Myc cDNA, MycHis, just 5' of the immunoglobulin heavy-chain enhancer, Eμ, are prone to B cell and plasma cell tumors. The predominant tumor (~50%) that arose in the iMycEμ mice on the mixed genetic background of segregating C57BL/6 and 129/SvJ alleles was LBL. The purpose of this study was to establish and characterize a cell line, designated iMycEμ-1, for the in-depth evaluation of LBL in vitro.

Methods

The morphological features and the surface marker expression profile of the iMycEμ-1 cells were evaluated using cytological methods and FACS, respectively. The cytogenetic make-up of the iMycEμ-1 cells was assessed by spectral karyotyping (SKY). The expression of the inserted MycHis gene was determined using RT-PCR and qPCR. Clonotypic immunoglobulin gene arrangements were detected by Southern blotting. The global gene expression program of the iMycEμ-1 cells and the expression of 768 "pathway" genes were determined with the help of the Mouse Lymphochip© and Superarray© cDNA micro- and macroarrays, respectively. Array results were verified, in part, by RT-PCR and qPCR.

Results

Consistent with their derivation from LBL, the iMycEμ-1 cells were found to be neoplastic IgMhighIgDlow lymphoblasts that expressed typical B-cell surface markers including CD40, CD54 (ICAM-1), CD80 (B7-1) and CD86 (B7-2). The iMycEμ-1 cells harbored a reciprocal T(9;11) and three non-reciprocal chromosomal translocations, over-expressed MycHis at the expense of normal Myc, and exhibited gene expression changes on Mouse Lymphochip© microarrays that were consistent with MycHis-driven B-cell neoplasia. Upon comparison to normal B cells using eight different Superarray© cDNA macroarrays, the iMycEμ-1 cells showed the highest number of changes on the NFκB array.

Conclusion

The iMycEμ-1 cells may provide a uniquely useful model system to study the growth and survival requirements of Myc-driven mouse LBL in vitro.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.